146 related articles for article (PubMed ID: 23067399)
1. Endoscopic TriModal imaging and biomarkers for neoplasia conjoined: a feasibility study in Barrett's esophagus.
Boerwinkel DF; Di Pietro M; Liu X; Shariff MK; Lao-Sirieix P; Walker CE; Visser M; O' Donovan M; Kaye P; Bergman JJ; Fitzgerald RC
Dis Esophagus; 2014 Jul; 27(5):435-43. PubMed ID: 23067399
[TBL] [Abstract][Full Text] [Related]
2. Inactivation of p16, RUNX3, and HPP1 occurs early in Barrett's-associated neoplastic progression and predicts progression risk.
Schulmann K; Sterian A; Berki A; Yin J; Sato F; Xu Y; Olaru A; Wang S; Mori Y; Deacu E; Hamilton J; Kan T; Krasna MJ; Beer DG; Pepe MS; Abraham JM; Feng Z; Schmiegel W; Greenwald BD; Meltzer SJ
Oncogene; 2005 Jun; 24(25):4138-48. PubMed ID: 15824739
[TBL] [Abstract][Full Text] [Related]
3. Autofluorescence-Directed Confocal Endomicroscopy in Combination With a Three-Biomarker Panel Can Inform Management Decisions in Barrett's Esophagus.
di Pietro M; Bird-Lieberman EL; Liu X; Nuckcheddy-Grant T; Bertani H; O'Donovan M; Fitzgerald RC
Am J Gastroenterol; 2015 Nov; 110(11):1549-58. PubMed ID: 26416188
[TBL] [Abstract][Full Text] [Related]
4. The combination of autofluorescence endoscopy and molecular biomarkers is a novel diagnostic tool for dysplasia in Barrett's oesophagus.
di Pietro M; Boerwinkel DF; Shariff MK; Liu X; Telakis E; Lao-Sirieix P; Walker E; Couch G; Mills L; Nuckcheddy-Grant T; Slininger S; O'Donovan M; Visser M; Meijer SL; Kaye PV; Wernisch L; Ragunath K; Bergman JJ; Fitzgerald RC
Gut; 2015 Jan; 64(1):49-56. PubMed ID: 24721904
[TBL] [Abstract][Full Text] [Related]
5. Third-generation autofluorescence endoscopy for the detection of early neoplasia in Barrett's esophagus: a pilot study.
Boerwinkel DF; Holz JA; Aalders MC; Visser M; Meijer SL; Van Berge Henegouwen MI; Weusten BL; Bergman JJ
Dis Esophagus; 2014 Apr; 27(3):276-84. PubMed ID: 23795645
[TBL] [Abstract][Full Text] [Related]
6. Aneuploidy in targeted endoscopic biopsies outperforms other tissue biomarkers in the prediction of histologic progression of Barrett's oesophagus: A multi-centre prospective cohort study.
Hadjinicolaou AV; van Munster SN; Achilleos A; Santiago Garcia J; Killcoyne S; Ragunath K; Bergman JJGHM; Fitzgerald RC; di Pietro M
EBioMedicine; 2020 Jun; 56():102765. PubMed ID: 32460165
[TBL] [Abstract][Full Text] [Related]
7. Endoscopic tri-modal imaging for detection of early neoplasia in Barrett's oesophagus: a multi-centre feasibility study using high-resolution endoscopy, autofluorescence imaging and narrow band imaging incorporated in one endoscopy system.
Curvers WL; Singh R; Song LM; Wolfsen HC; Ragunath K; Wang K; Wallace MB; Fockens P; Bergman JJ
Gut; 2008 Feb; 57(2):167-72. PubMed ID: 17965067
[TBL] [Abstract][Full Text] [Related]
8. Endoscopic video-autofluorescence imaging followed by narrow band imaging for detecting early neoplasia in Barrett's esophagus.
Kara MA; Peters FP; Fockens P; ten Kate FJ; Bergman JJ
Gastrointest Endosc; 2006 Aug; 64(2):176-85. PubMed ID: 16860064
[TBL] [Abstract][Full Text] [Related]
9. Endoscopic video autofluorescence imaging may improve the detection of early neoplasia in patients with Barrett's esophagus.
Kara MA; Peters FP; Ten Kate FJ; Van Deventer SJ; Fockens P; Bergman JJ
Gastrointest Endosc; 2005 May; 61(6):679-85. PubMed ID: 15855971
[TBL] [Abstract][Full Text] [Related]
10. [The molecular genetic alterations in mucosa of intestines as markers of oncologic progression and estimate of effectiveness of anti-reflux operations in patients with Barrett's esophagus].
Osminin SV; Vetshev FP; Rudenko VV; Zaletaev DV; Khorobrykh TV; Nemtsova MV
Klin Lab Diagn; 2016 Oct; 61(10):681-5. PubMed ID: 30615323
[TBL] [Abstract][Full Text] [Related]
11. Effects of autofluorescence imaging on detection and treatment of early neoplasia in patients with Barrett's esophagus.
Boerwinkel DF; Holz JA; Kara MA; Meijer SL; Wallace MB; Wong Kee Song LM; Ragunath K; Wolfsen HC; Iyer PG; Wang KK; Weusten BL; Aalders MC; Curvers WL; Bergman JJ
Clin Gastroenterol Hepatol; 2014 May; 12(5):774-81. PubMed ID: 24161353
[TBL] [Abstract][Full Text] [Related]
12. Population-based study reveals new risk-stratification biomarker panel for Barrett's esophagus.
Bird-Lieberman EL; Dunn JM; Coleman HG; Lao-Sirieix P; Oukrif D; Moore CE; Varghese S; Johnston BT; Arthur K; McManus DT; Novelli MR; O'Donovan M; Cardwell CR; Lovat LB; Murray LJ; Fitzgerald RC
Gastroenterology; 2012 Oct; 143(4):927-35.e3. PubMed ID: 22771507
[TBL] [Abstract][Full Text] [Related]
13. Prospective study of cyclin D1 overexpression in Barrett's esophagus: association with increased risk of adenocarcinoma.
Bani-Hani K; Martin IG; Hardie LJ; Mapstone N; Briggs JA; Forman D; Wild CP
J Natl Cancer Inst; 2000 Aug; 92(16):1316-21. PubMed ID: 10944553
[TBL] [Abstract][Full Text] [Related]
14. A multicenter, double-blinded validation study of methylation biomarkers for progression prediction in Barrett's esophagus.
Jin Z; Cheng Y; Gu W; Zheng Y; Sato F; Mori Y; Olaru AV; Paun BC; Yang J; Kan T; Ito T; Hamilton JP; Selaru FM; Agarwal R; David S; Abraham JM; Wolfsen HC; Wallace MB; Shaheen NJ; Washington K; Wang J; Canto MI; Bhattacharyya A; Nelson MA; Wagner PD; Romero Y; Wang KK; Feng Z; Sampliner RE; Meltzer SJ
Cancer Res; 2009 May; 69(10):4112-5. PubMed ID: 19435894
[TBL] [Abstract][Full Text] [Related]
15. Advanced pathology under squamous epithelium on initial EMR specimens in patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma: implications for surveillance and endotherapy management.
Chennat J; Ross AS; Konda VJ; Lin S; Noffsinger A; Hart J; Waxman I
Gastrointest Endosc; 2009 Sep; 70(3):417-21. PubMed ID: 19555948
[TBL] [Abstract][Full Text] [Related]
16. Value of cyclin A immunohistochemistry for cancer risk stratification in Barrett esophagus surveillance: A multicenter case-control study.
van Olphen SH; Ten Kate FJC; Doukas M; Kastelein F; Steyerberg EW; Stoop HA; Spaander MC; Looijenga LHJ; Bruno MJ; Biermann K;
Medicine (Baltimore); 2016 Nov; 95(47):e5402. PubMed ID: 27893678
[TBL] [Abstract][Full Text] [Related]
17. Molecular genetic analysis of surveillance biopsy samples from Barrett's mucosa--significance of sampling.
Werther M; Saure C; Pahl R; Schorr F; Rüschoff J; Alles JU; Heinmöller E
Pathol Res Pract; 2008; 204(5):285-94. PubMed ID: 18337019
[TBL] [Abstract][Full Text] [Related]
18. Quantitative analysis of p16 methylation in Barrett's carcinogenesis.
Chueca E; Valero A; Hördnler C; Puertas A; Carrera P; García-González MA; Strunk M; Lanas A; Piazuelo E
Ann Diagn Pathol; 2020 Aug; 47():151554. PubMed ID: 32570024
[TBL] [Abstract][Full Text] [Related]
19. Clinical utility and interobserver agreement of autofluorescence imaging and magnification narrow-band imaging for the evaluation of Barrett's esophagus: a prospective tandem study.
Giacchino M; Bansal A; Kim RE; Singh V; Hall SB; Singh M; Rastogi A; Moloney B; Wani SB; Gaddam S; Mathur SC; Wallace MB; Kanakadandi V; Balasubramanian G; Gupta N; Sharma P
Gastrointest Endosc; 2013 May; 77(5):711-8. PubMed ID: 23433595
[TBL] [Abstract][Full Text] [Related]
20. Trimodal imaging-assisted endoscopic mucosal resection of early Barrett's neoplasia.
Thomas T; Singh R; Ragunath K
Surg Endosc; 2009 Jul; 23(7):1609-13. PubMed ID: 19296171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
